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Chimeric toxic protein was prepared from the mistletoe lectin I A-chain and ricin B-chain by using the disulfide exchange reaction. Ricin and 
chimeric protein were indistinguishable inbinding to immobilized asialofetuin in ELISA. Chimeric protein was more toxic to Jurkat cells than native 
mistletoe lectin I, but not so effective as native ricin. In the presence of NH&l, which enhances the toxicity of some toxins and immunotoxins, 
but does not influence ricin toxicity, both ricin and chimeric toxin had equal cytotoxic activity. The possibility is discussed that the ricin B-chain 
protects the ricin A-chain (RTA) from degradation during delivering RTA from the cell surface to the place where RTA is translocated into the 
cytosol. 
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1. INTRODUCTION 
During the last years a lot of effort has been made to 
prepare hybrid cytotoxic proteins consisting of the en- 
zymatically active A-chains of different toxins like ricin, 
and antibodies or other polypeptides which selectively 
bind to cell surface molecules [1,2]. The aim of these 
investigations is to produce directed cytotoxic agents 
which are able to selectively kill defined groups of cells, 
e.g. malignant cells. Although the resulting conjugates 
have a very high specificity of binding to target cells 
when compared with natural toxins, most of these con- 
jugates are much less toxic than native toxins. This is 
most likely due to inefficient transfer of the A-chains of 
hybrids from the cell surface into the cytosol. The ra- 
tional design of directed cytotoxins requires a better 
understanding of the entry mechanism of toxin A- 
chains and will reveal factors that interfere in this proc- 
ess. 
active MLA and RTA into the cell, we have prepared 
a chimeric protein (MLA/RTB) from the ML1 A-chain 
and ricin B-chain and compared the cytotoxic proper- 
ties of this chimeric protein with those of the native 
parent toxins. 
2. MATERIALS AND METHODS 
Ricin and its subunits were isolated as described earlier [5]. Mistle- 
toe lectin I was isolated from l&urn album and MLA was purified 
according to [6]. 
2.1. Preparation of chimeric toxin 
Recently it was shown that immunotoxins (IT) con- 
structed by utilizing the ML1 A-chain had the same 
cytotoxic activity as the native ML1 and were more 
effective when compared to ITS constructed by utilizing 
the ricin A-chain [3,4]. In attempts to elucidate the role 
of the binding moiety in the entry of the enzymatically 
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Abbreviations: MLI, mistletoe lectin I; MLA, mistletoe lectin I A- 
chain; RTA, ricin A-chain; RTB, ricin B-chain; IT, immunotoxin; 
DTT, dithiotreitol; PBS, phosphate-buffered saline; BSA, bovine 
serum albumin. 
Chimeric toxic protein was prepared using the disulfide exchange 
reaction. Isolated RTB was incubated with 5 mM of Elhnan’s reagent 
(5,5’-dithiobis-(2-nitrobenzoic acid)) for 30 min at 2O’C. Excess rea- 
gent was removed by gel filtration. Before conjugation MLA was 
incubated with 50 mM DTT for 30 min at 20°C followed by removing 
excess DTT. Collected RTB and MLA were immediately mixed, and 
incubated overnight at 20°C. The resulting chimeric toxin was purified 
from unreacted proteins by gel filtration on the prepacked column HR 
10 x 30 with Superdex G-75 using an FPLC system (Pharmacia, Swe- 
den) and analyzed by SDS-PAGE. Protein bands were visualized by 
Coomasie brilliant blue R-250 staining or the proteins were electro- 
phoretically transferred to nitrocellulose membrane. After transfer, 
the nitrocellulose membranes were blocked with 1% BSA, 0.1% 
Tween-20,20 mM lactose and incubated with a biotinylated monoclo- 
nal antibody to MLA (10 &/ml in PBS with 0.1% BSA and 0.1% 
Tween-20,20 mM Lactose). After washing, the blots were incubated 
with streptavidin conjugated to peroxidase and developed with a sub- 
strate solution containing 3,3’-diaminobenzidme. The amount of 
chimeric protein in the sample was then estimated from densitogram 
of the Coomassie-stained gel. 
Cytotoxicity assays were carried out on the T-lymphoblast Jurkat 
cell line by measuring the inhibition of [‘Hlthymidine incorporation 
as described in [7]. 
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Fig. 1. Purification of chimeric toxin on Superdex G-75 HR 10 x 30. 
500 ~1 of reacted mixture was loaded on the column with flow rate 0.5 
ml/min in PBS containing 20 mM n-lactose and 1 ml fractions were 
collected. 
Proteins were radiolabeled using Iodo-Gen (1,3.4,6-tetra-chloro- 
3a,6a-diphenylglycouril; Sigma, USA) according to [8]. The binding 
assay of [‘251]proteins was prepared as described in [7]. 
3. RESULTS 
3.1. Preparation of chimeric toxin 
To prepare the chimeric protein MLA/RTB consist- 
ing of the ricin B-chain and the ML1 A-chain, the iso- 
lated ricin B-chain was treated with Ellman’s reagent o 
generate the activated disulfide. Freshly reduced ML1 
A-chain was mixed with derivatized RTB to form (via 
thiol disulfide interchange) a disulfide-linked conjugate, 
like native toxins. The resulting material (MW 60 kDa) 
was purified from unreacted toxin subunits and ana- 
lyzed by electrophoresis and blotting. Gel filtration 
chromatography on Superdex G-75 showed that ap- 
proximately 90% of the mixed proteins had formed high 
molecular weight material (Fig. 1). The material after 
purification only contained chimeric protein consisting 
of ricin B-chain and ML1 A-chain (Fig. 2A and B). 
Purified chimeric toxin inhibits the binding of biotinyl- 
ated ricin to asialofetuin to the same extent as native 
ricin (results not shown). 
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Fig. 2. Electrophoresis and blotting purified chimeric toxin. Fraction 
10 designated on Fig. 1 was analyzed by electrophoresis on a 7.522% 
gradient polyacrylamide gel. Lane 1, sample prepared without 2-mer- 
captoethanol; ane 2, sample prepared with 2-mercaptoethanol. Frac- 
tion 10 designated on Fig. 1 after elcctrophoresis was transferred to 
a nitrocellulose membrane and treated as described in section 2. Lanes 
1 and 2, as in Fig. 2A. 
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Fig. 3. Cytotoxic effect of native toxins and the chimeric toxin on 
Jurkat cells. The results are expressed as percentage of [‘Hlthymidine 
incorporation of untreated cells (about 100,000 cpm) corrected for 
background value. (o-o, l 4), MLI; (A-A, A-A), MLA/RTB; 
(o--o, em), ricin. Cells were incubated without NH&l; Cells were 
incubated in the presence of 10 mM NH&l. 
3.2. Toxicity of the chimeric toxin 
The toxicity of the chimeric toxin to Jurkat cells was 
compared with that of native toxins which had different 
cytotoxic activity to these cells. The native ML1 was 
about 25 times less toxic than native ricin (Fig. 3A). In 
order to elucidate the role of toxin binding to cell targets 
as opposed to cytotoxic activity we quantified the num- 
ber of binding sites on Jurkat cells for both toxins (Fig. 
4). It was found that the maximal number of binding 
sites on these cells was 5.43 x lo6 for ML1 and 8.8 x lo6 
for ricin, respectively. Because ML1 and ricin have ap- 
proximately the same K, (0.7 x lo8 M-’ and 0.8 x 10’ 
M-l, respectively), this slight difference in number of 
binding sites cannot explain the higher activity of ricin 
when compared to MLI. Chimeric toxic protein, which 
exhibits the same binding ability as native ricin, was less 
toxic for Jurkat cells than ricin and only slightly more 
active than native ML1 (Fig. 3A). 
Both native toxins differ in their sensitivity to poten- 
tiating with NH4Cl (Fig. 3B). Native ML1 was about 10 
times more toxic for cells when 10 mM NH,Cl was 
included in the incubation mixture than in the absence 
of NH&l. In contrast, the activity of native ricin could 
not be potentiated with NH&l and ricin had the same 
toxicity in the presence of NH&l as in its absence. 
Chimeric protein MLA/RTB was significantly more ac- 
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Fig. 4. Binding of ‘*‘I-labeled ricin and ML1 in Scatchard coordinates. 
Specific binding was calculated for each point by subtracting the 
amount of iodinated proteins bound in the presence of 50 mM D- 
lactose (less that 10% of total counts bound); (0-X ricin; (O-O), MLI. 
B, bound protein (ng); F, free protein (ng). 
tive in the presence of NH&l and exposed the same 
cytotoxic activity as native ricin (Fig. 3B). 
4. DISCUSSION 
The structure and lectin properties of ML1 and ricin 
were described in a number of reviews [ 1,2]. Both toxins 
have similar structures and mechanisms of action. They 
have galactose-binding sites on their B-chains, but both 
toxins differ in their specificity for galactose-terminated 
complex oligosa~harides exposed on the cell surface 
[9], Therefore they will occupy a different quantity and 
quality of binding sites on the cell surface, which partly 
explains the difference in cytotoxic activity of these tox- 
ins because their A-subunits have approximately the 
same enzymatic activity [lo]. 
Enzymatically active A-subunits of both toxins were 
used for preparing antibody-containing immunotoxins. 
The immunotoxins containing MLA were more toxic 
than IT-RTA and were as toxic as native ML1 [3,4], 
whereas the immunotoxins prepared from the ricin A- 
chain were much less active than the parent native toxin. 
Cytotoxicity of the ricin A-chain containing immuno- 
toxins could be greatly potentiated by a number of 
agents, e.g. monensin and NH&l. Furthermore, it is 
more important that the toxicity of these RTA-immu- 
notoxins could be potentiated by treatment of the cells 
with ricin B-chain alone [I l] or with ricin B-chain cou- 
pled to directing antibodies [12]. In addition, immuno- 
toxins prepared by coupling native ricin to monoclonal 
antibodies are generally more toxic to target cells than 
immunotoxins prepared from the isolated ricin A-chain. 
One hypothesis explaining these findings is that the ricin 
B-chain can disrupt the membrane structure of an intra- 
cellular vesicle and form a pore that allows the A-chain 
to pass into the cytosol. However, although the interac- 
tion of the ricin B-chain with the liposomal membrane 
has been demonstrated in a number of investigations 
[13,14], the evidence that this interaction is involved in 
the translocation of RTA is still lacking. 
Our findings suggest hat the facilitating role of the 
ricin B-chain is mainly to prevent the ricin A-chain from 
degradation during their processing in the cells. The 
ricin A-chain uses this route with maximal efficacy 
which could be achieved by MLA coupled to the ricin 
B-chain only in the presence of NI&Cl slowing down 
acidification in the phagosome. 
Earlier we demonstrated that the ricin B-chain inter- 
acts with the ricin A-chain with high affinity and that 
this interaction is pH-dependent: K, at pH 5.0 is IO-fold 
higher than at pH 7.5 [15]. In contrast, interaction be- 
tween RTB and MLA was much weaker and pH-inde- 
pendent [16]. Just this high affinity interaction between 
the ricin subunits can provide the decreasing degrada- 
tion of RTA in the acid intracellular vesicles and explain 
the facilitating moiety of the ricin B-chain. 
The protective capability of the ricin B-chain revealed 
in the present work might be useful for the constructing 
new effective recombinant immunotoxins. 
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